Relypsa's stock rockets on heavy volume after buyout deal
Shares of Relypsa Inc. rocketed 59% in active premarket trade Thursday, after the biopharmaceutical company agreed to be acquired by Switzerland-based Galencia Group in a deal valued at $1.53 billion. Under terms of the deal, Relypsa shareholders will receive $32 in cash for each share they own. That represents a 59% premium to Wednesday's closing price of $20.10, and is a level the stock hasn't traded at since Aug. 6, 2015. The deal is expected to close in the current third quarter. Volume topped... Читать дальше...